I think its worth debating. I am neutral on this whole
I think its worth debating. I am neutral on this whole thing, as I think that this is a very fluid situation, and there is likely more that we don't know, than we actually do know.
I would rather not upset the apple cart, but I also value accountability. The challenge is figuring out how this will unfold.
We don't know where we will be in 3 months, nor do we know who they may appoint as alternatives. I feel like a level headed decision will require knowledge of both of those variables.
9
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Wounded Warriors Gala: A Night of Heroic Honors In the swirling hum of Washington's gala scene, the Wounded Warrior Project (WWP) cuts through the noise with a sharp and poignant reminder of patriotism and community support. Their Courage Awards & Benefit Dinner®, pumped with the gravitas of corporate backing from the likes of Goldman Sachs, showcased a heartfelt...
Continue Reading
Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...
Continue Reading
Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...
Continue Reading
Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...
Continue Reading
New Kid on the Block: Cheez Nugs Buckle up folks, Crimson Coward is at it again. They're rolling out something they claim will blow your taste buds straight out of the water: Cheez Nugs. Dropping nationwide on September 18, 2026, these aren't your run-of-the-mill cheese bites. We're talking 100% whole-milk mozzarella, a golden herb-seasoned crust, and a mouthful of creamy...
Continue Reading
The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...
Continue Reading
A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...
Continue Reading
What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...
Continue Reading
Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...
Continue Reading
Pushing AI Regulations into High Gear I'll tell you what—it's about time somebody shook things up in the AI world with more than empty promises. Governor Newsom's executive order is doing just that, fast-tracking the timeline for implementing California's SB 813. This move is like giving speed boots to the legislative process, revving up the rules to ensure AI doesn't...
Continue Reading
Top 5 Most Recently Viewed Articles
Xinjiang's Remarkable Transformation Over 70 Years This year marks the 70th anniversary of the establishment of the Xinjiang Uygur autonomous region. As we reflect on its significant journey, Xinjiang has evolved into a vital region that not only supports the national economy but also enriches the social fabric of China with its unique culture and historic significance....
Continue Reading
Citi's New Leadership in Data Management Citigroup has undergone major changes in its leadership structure to tackle ongoing challenges in data management. Tim Ryan, who heads technology, will work closely with Chief Operating Officer Anand Selva on key initiatives aimed at improving data governance and management within the bank. Ryan and Selva's Collaborative Efforts...
Continue Reading
Legend Senior Living Expands Its Reach In an exciting development, Legend Senior Living®, a respected name in the senior living industry, recently announced its expansion with the acquisition of two new residences. This announcement marks the company's first entry into Missouri, integrating the newly acquired property, The Vero of O'Fallon, into its growing portfolio....
Continue Reading
Jason Stabell Invests Significantly in Epsilon Energy Recently, Jason Stabell, the Chief Executive Officer of Epsilon Energy, executed a substantial insider purchase of shares in the company, signaling his strong confidence in its growth potential. This insider transaction, disclosed through recent legal filings, showcases his commitment to the company’s future. The...
Continue Reading
Exciting Developments Around Revumenib in AML Treatment In the world of innovative cancer therapies, the recent publication of data from the BEAT AML trial highlights significant advances with Syndax Pharmaceuticals' Revumenib. This first-in-class, selective menin inhibitor showcases its potential when combined with venetoclax and azacitidine, particularly for older...
Continue Reading